Microautoradiography of [123I]ADAM in mice treated with fluoxetine and serotonin reuptake inhibitors

Nuclear Medicine and Biology

Volumn 31, Issue 5, 2004, Pages 557-562

  Ye, Xin Xian ^a   Chen, Jyh Cheng ^a   Liu, Ren Shen ^b   Wey, Shiaw Pyng ^c   Lee, Jin Shin ^a   Chen, Chia Chieh ^d   Fu, Ying Kai ^d   Ting, Gann ^d   Hwang, Jeng Jong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

123I ADAM; Desipramine; Fluoxetine; Microautoradiography; p Chloroamphetamine; Phosphor plate imaging

Indexed keywords

2 [[2 [(DIMETHYLAMINO)METHYL]PHENYL]THIO] 5 IODOPHENYLAMINE I 123; CHLORAMPHETAMINE; DESIPRAMINE; FLUOXETINE; NARCOTIC AGENT; PSYCHOTROPIC AGENT; RADIOPHARMACEUTICAL AGENT; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; 2 ((2 ((DIMETHYLAMINO)METHYL)PHENYL)THIO) 5 IODOPHENYLAMINE; 2-((2-((DIMETHYLAMINO)METHYL)PHENYL)THIO)-5-IODOPHENYLAMINE; ADRENERGIC RECEPTOR AFFECTING AGENT; CARRIER PROTEIN; CINANSERIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; SEROTONIN; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN FUNCTION; BRAIN STEM; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SELECTIVITY; MALE; MESENCEPHALON; MOUSE; NONHUMAN; SEROTONINERGIC NERVE CELL; STATISTICAL SIGNIFICANCE; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; AUTORADIOGRAPHY; BRAIN; CINANSERIN; DESIPRAMINE; FLUOXETINE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; P-CHLOROAMPHETAMINE; RADIOPHARMACEUTICALS; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TISSUE DISTRIBUTION;

EID: 3042620342     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2003.12.002     Document Type: Article

References (21)

1. 123I]IDAM. Eur J Nucl Med. 26:1999;854-861
2. Bligh-Glover W., Kolli T.N., Shapiro-Kulnane L., Dilley G.E., Friedman L., Balraj E., Rajkowska G., Stockmeier C.A. The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry. 47:2000;1015-1024
3. Grass-Isseroff R., Biegon A., Voet H., Weizman A. The suicide brain a review of postmortem recepotor/transporter binding studies. Neurosci Biobehav Rev. 22:1998;653-661
4. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry. 44:1998;1090-1098
5. 123I]- Beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry. 47:2000;482-489
6. Erling T.M., Bolwig T.G., Dam H., Plenge P. The serotonin transporter in depress patients a qualitative study based on dissocation kinetics. Biol Psychiatry. 38:1995;699-700
7. Kung H.F., Wey S.P., Kung M.P. SPECT imaging agents for dopamine and serotonin transporters in the rat brain. Ann Nucl Med Sci. 13:2000;165-174
8. 123I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur J Nucl Med. 26:1999;844-853
9. Pineyro G., Blier P. Autoregulation of serotonin neurons role in antidepressant drug action. Pharmacol Rev. 51:1999;534-579
10. 125I]ADAM to serotonin transporters in rat brain. Synapse. 38:2000;403-412
11. Oya S., Choi S.R., Hou C., Mu M., Kung M.P., Acton P.D., Siciliano M., Kung H.F. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM) an improved serotonin transporter ligand. Nucl Med Biol. 27:2000;249-254
12. Tauscher J., Pirker W., Zwaan M., Asebaum S., Bruke T. In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. Eur Neuropsychopharmacol. 9:1999;177-179
13. Hunskaar S., Berge O.G., Broch O.J., Hole K. Lesions of the ascending serotonergic pathways and antinociceptive effects after systemic administration of p-chloroamphetamine in mice. Pharmacol Biochem Behav. 24:1986;709-714
14. Miller K.J., Anderholm D.C., Ames M.M. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations. Biochem Pharmacol. 35:1986;1737-1742
15. 123I]ADAM in mice correlation with whole body autoradiography. Nucl Med Biol. 29:2002;643-650
16. Franklin K.B.J., Paxinos G. The mouse brain in sereotaxic coordinates. 1996;Academic Press, San Diego
17. Booij J., Knol R.J., Reneman L., De Bruin K., Janssen A.G., Van Royen E.A. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. Eur J Nucl Med. 25:1998;1666-1669
18. 18F-Fluoxetion in the rodent brain an in vitro and in vivo study. Nucl Med Biol. 25:1998;605-610
19. 3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Intl J Immunopharmacol. 21:1999;631-646
20. 1B mRNA in the sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology. 15:1996;515-522
21. Ames M.M., Frank S.K. Stereochemical aspects of para-chloroamphetamine metabolism. Rabbit liver microsomal metabolism of RS-, R(-)- and S(+)-para-chloroamphetamine. Biochem Pharmacol. 31:1982;5-9